Elaidi, R. Harbaoui, A. Beuselinck, B. Eymard, J.-C. Bamias, A. De Guillebon, E. Porta, C. Vano, Y. Linassier, C. Debruyne, P.R. Gross-Goupil, M. Ravaud, A. Aitelhaj, M. Marret, G. Oudard, S., Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma, Annals of Oncology, (26), 378-385, 2015, Oxford University Press, 0923-7534, 1569-8041